Thomson Health head steps down

Share this article:
Kevin King, president and CEO of Thomson Healthcare, has left the company. It remains unclear whether he will be replaced, company officials said.

King left the firm towards the end of June. He arrived in March of 2005 from GE Medical Systems Information Technologies and GE Global Clinical Systems. His responsibilities are being absorbed by Bob Cullen, president and CEO of Thomson Scientific and Healthcare.

Thomson announced last month that it would divest its medical education business, which pulled in $97 million in revenue for 2005, accounting for about one tenth of the scientific and healthcare group's total revenues.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union